NEU 5.56% $20.91 neuren pharmaceuticals limited

A possibility worth worth contemplating, page-11

  1. 11,699 Posts.
    lightbulb Created with Sketch. 1689
    acl's phase 2 was open label, their phase 3 wasn't.

    neu's phase 2 was double blinded with a patient group that was very unlikely to be effected by the placebo effect.

    In neu's phase 2 the placebo patients showed little alteration. The lower dose showed improvement and the higher dose showed good improvement. Just what one want's to see.

    There's still risk, but I agree that acl and neu are world's apart.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$20.91
Change
-1.230(5.56%)
Mkt cap ! $2.663B
Open High Low Value Volume
$22.06 $22.11 $20.63 $5.767M 270.7K

Buyers (Bids)

No. Vol. Price($)
11 299 $20.90
 

Sellers (Offers)

Price($) Vol. No.
$20.91 11 1
View Market Depth
Last trade - 14.23pm 18/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.